In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.
Sci Adv
; 8(26): eabl8247, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35767614
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triple Negative Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Sci Adv
Year:
2022
Type:
Article
Affiliation country:
China